Ganoderic acid G and I and ganolucidic acid A and B, new triterpenoids from Ganoderma lucidum. (Q78435475)

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.33.2628

14 December 2019

title

Ganoderic acid G and I and ganolucidic acid A and B, new triterpenoids from Ganoderma lucidum. (English)

1 reference

14 December 2019

1 reference

(2S,6S)-6-hydroxy-2-methyl-4-oxo-6-[(3S,5R,7S,10S,12S,13R,14R,17S)-3,7,12-trihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]heptanoic acid

1 reference

methyl (2R,6R)-6-[(5R,10S,13R,14R,15S,17S)-15-hydroxy-4,4,10,13,14-pentamethyl-3,11-dioxo-2,5,6,7,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoate

1 reference

(6S)-6-[(3S,7S,10S,13R,14R,17S)-3,7-dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-4-oxoheptanoic acid

1 reference

(2R,6R)-6-[(5S,10S,13R,14S,15S,17S)-15-hydroxy-4,4,10,13,14-pentamethyl-3,11-dioxo-2,5,6,7,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid

1 reference

15-Hydroxy-3,11,23-trioxolanost-8-en-26-oic acid

1 reference

methyl (2R,6R)-6-[(3S,5R,10S,13R,14R,15S,17S)-3,15-dihydroxy-4,4,10,13,14-pentamethyl-11-oxo-1,2,3,5,6,7,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoate

1 reference

methyl (2R,6S)-6-[(3S,5R,7S,10S,13R,14R,17S)-3,7-dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-4-oxoheptanoate

1 reference

(2S,6S)-6-[(3S,5R,10R,13S,14S,15S,17S)-3,15-dihydroxy-4,4,10,13,14-pentamethyl-11-oxo-1,2,3,5,6,7,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid

1 reference

1 reference

methyl (2R,6R)-2-methyl-4-oxo-6-[(3S,5R,7S,10S,12S,13R,14R,17R)-3,7,12-trihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]heptanoate

1 reference

1 reference

Tohru Kikuchi

1

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.33.2628

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.33.2628

14 December 2019

Satoko Matsuda

series ordinal

2

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.33.2628

14 December 2019

Yoshihiro Murai

series ordinal

3

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.33.2628

14 December 2019

Zenichi Ogita

series ordinal

4

1 reference

14 December 2019

language of work or name

English

1 reference

Chemical & Pharmaceutical Bulletin

publication date

1985

3 references

16 September 2022

16 September 2022

full work available at URL

https://www.jstage.jst.go.jp/article/cpb1958/33/6/33_6_2628/_pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1248/cpb.33.2628?email=unpaywall_01@example.com

published in

Chemical & Pharmaceutical Bulletin

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.33.2628

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.33.2628

14 December 2019

volume

33

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.33.2628

14 December 2019

issue

6

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.33.2628

14 December 2019

page(s)

2628-2631

1 reference

14 December 2019

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1248/cpb.33.2628?email=unpaywall_01@example.com

access restriction status

open access

1 reference

based on heuristic

inferred from online access status

Identifiers

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.33.2628